High Net Worth Investment Fraud Attorney for Accredited Investors

Accredited investors and high-net-worth individuals occupy a distinct position in the securities markets. Their wealth often unlocks access to private placements, hedge funds, and alternative investments that are commonly restricted to accredited or sophisticated investors. That same access can make them attractive targets for fraudulent private offerings, especially where promoters rely on limited disclosure and investor-sophistication assumptions. Brokers who recommend unsuitable complex products, advisers who breach their fiduciary duties, and promoters who misuse Regulation D (Reg D) exemptions — particularly Rule 506(b) and Rule 506(c) — can expose investors to concentrated losses.

At Varnavides Law, PC, we represent accredited investors who have suffered significant losses — typically $100,000 or more — due to broker misconduct, investment adviser fraud, and fraudulent private securities offerings. That practice is grounded in a decade of experience on the defense side of Financial Industry Regulatory Authority (FINRA) arbitration, giving us insight into how financial firms build their defenses, where their documentation gaps lie, and what evidence drives recovery for investors.

Why High-Net-Worth Investors Are Prime Targets

The Securities and Exchange Commission defines an accredited investor for Regulation D purposes, in relevant part, as an individual with a net worth exceeding $1 million (excluding the value of a primary residence) or annual income of at least $200,000 individually — or $300,000 combined with a spouse or spousal equivalent — for each of the two most recent years, with a reasonable expectation of reaching the same income level in the current year. Separately, the SEC’s August 2020 final rule, Release No. 33-10824, expanded accredited investor status to holders of Series 7, 65, and 82 licenses in good standing. These thresholds are codified at 17 C.F.R. § 230.501(a).

Under 17 C.F.R. § 230.506, Rule 506(b) permits sales to accredited investors without general solicitation, and Rule 506(c) permits general solicitation but restricts purchasers to verified accredited investors.

Accredited-investor status is separate from a broker’s recommendation duties. For retail-customer recommendations made on or after June 30, 2020, Reg BI governs broker-dealer conduct. FINRA Rule 2111 remains relevant for recommendations not subject to Reg BI, non-retail or institutional contexts, and pre-Reg BI conduct. In each setting, the analysis turns on the customer’s investment profile and the product’s risks, not merely the investor’s wealth.

Accredited investor status carries a critical consequence: it qualifies individuals for private placement offerings that are exempt from 15 U.S.C. § 77e (Securities Act registration requirements) under Regulation D and 15 U.S.C. § 77d(a)(2) (the private offering exemption). Rule 506(b) allows sales to up to 35 non-accredited sophisticated investors and unlimited accredited investors, provided the issuer does not use general solicitation. FINRA Rule 3280 governs “selling away” — private securities transactions conducted outside the broker’s employing firm — and broker recommendation duties may arise under Reg BI or FINRA suitability rules depending on the customer, timing, and facts. For accredited investors, Reg D offerings generally do not require a statutory prospectus or the specified Rule 502(b) disclosure package required for non-accredited purchasers in certain Rule 506(b) offerings. Promoters of fraudulent private placements rely on this disclosure gap to conceal material risks, fabricate financial projections, and misappropriate investor funds without the scrutiny that public offerings face.

The SEC’s fiscal year 2025 enforcement report documented $17.9 billion in monetary relief and identified offering frauds, insider trading, market manipulation, issuer disclosure violations, and investment adviser fiduciary breaches among the misconduct categories addressed by the SEC. Those enforcement priorities reflect the same risk categories that frequently appear in high-value investor-loss claims: undisclosed conflicts, misleading offering documents, misuse of investor funds, and adviser or promoter misconduct. Source: SEC, Fiscal Year 2025 Enforcement Results (Apr. 2026).

Common Fraud Schemes Targeting Accredited Investors

High-net-worth investors encounter a distinct set of fraud patterns. Understanding the mechanics of these schemes — and the legal theories that address them — is essential to evaluating potential claims.

Private Placement Fraud and Regulation D Abuse

Regulation D exemptions — primarily Rule 504 (17 C.F.R. § 230.504), Rule 506(b) (17 C.F.R. § 230.506(b)), and Rule 506(c) (17 C.F.R. § 230.506(c)) — permit issuers to sell securities to accredited investors without registering under 15 U.S.C. § 77e (Securities Act registration requirements). Rule 506(b) allows sales to up to 35 non-accredited sophisticated investors and unlimited accredited investors. Rule 506(c) permits general solicitation but restricts sales to verified accredited investors. FINRA Rule 3280 requires associated persons to give prior written notice before participating in a private securities transaction; if selling compensation is involved, the firm must approve or disapprove participation in writing. These exemptions are legitimate tools for capital formation, but they can also be misused in fraudulent private placements.

Common patterns in private placement fraud include: fabricated financial statements and inflated valuations; misrepresentation of the use of proceeds; undisclosed conflicts of interest between the issuer and placement agent; false or misleading promised-return claims; and complete misappropriation of funds through related-party transfers. FINRA Rule 2150 also prohibits member firms from guaranteeing customers against loss. In California, private placement fraud can trigger rescission remedies under Cal. Corp. Code § 25501 when the investor bought from a seller who violated Cal. Corp. Code § 25401’s prohibition on materially misleading statements in securities transactions.

Ponzi Schemes

Ponzi schemes pay purported returns to earlier investors using capital contributed by newer participants rather than from legitimate investment activity. Ponzi schemes depend on continuing inflows from new investors, and high-net-worth victims may suffer especially large losses when they make substantial commitments. The SEC’s Office of Investor Education and Advocacy identifies common Ponzi red flags including high-return/low-risk promises, unregistered investments, unlicensed sellers, complex strategies, paperwork problems, and difficulty receiving payments. Source: SEC Investor Alert, Ponzi Schemes Using Virtual Currencies.

Ponzi schemes frequently operate through the same private placement structures described above. An issuer raises funds under a Reg D exemption, representing that investor capital will be deployed in a specific strategy; instead, early investors receive payments from later investors’ contributions. When new capital stops flowing, the scheme collapses.

Broker Misconduct: Unsuitable Recommendations and Excessive Fees

Reg BI governs broker-dealers and their associated persons and has applied to covered retail-customer recommendations since June 30, 2020. Reg BI imposes four distinct obligations when a broker makes a recommendation of any securities transaction or investment strategy involving securities to a retail customer:

FINRA Rule 2111 remains important, but it must be applied with its current Reg BI carveout. It does not apply to recommendations subject to Reg BI; it remains relevant for non-Reg-BI recommendations, pre-June 30, 2020 conduct, and claims where FINRA suitability principles help explain industry standards or supervisory failures.

For high-net-worth clients, broker misconduct frequently takes the form of concentrated-position recommendations in illiquid alternative investments or non-traded real estate investment trusts (REITs) that carry substantial early redemption penalties; excessive management fees or wrap-fee arrangements that erode returns; unsuitable variable annuity exchanges or replacements that trigger surrender charges or restart surrender periods; unauthorized reallocations among annuity sub-accounts that create improper risk exposure; and failure to supervise junior brokers who recommend complex products without adequate product knowledge under Reg BI’s Care Obligation or, where applicable, FINRA Rule 2111’s reasonable-basis suitability principles.

Investment Adviser Fiduciary Breaches

Registered investment advisers (RIAs) registered with the SEC under the Investment Advisers Act of 1940 owe a full fiduciary duty to their clients under § 206 of that Act, 15 U.S.C. § 80b-6. This fiduciary duty — confirmed in SEC v. Capital Gains Research Bureau, Inc., 375 U.S. 180 (1963) — requires an adviser to act in the client’s best interest and to provide full and fair disclosure of all material conflicts of interest. The fiduciary standard applicable to RIAs is higher than the Care Obligation imposed on broker-dealers under Reg BI.

Common investment adviser fiduciary breaches affecting high-net-worth clients include: undisclosed revenue-sharing arrangements with product sponsors; self-dealing through recommending proprietary funds with higher fees than comparable alternatives; failure to disclose that the adviser charges wrap fees covering trading costs while simultaneously engaging in excessive rebalancing; and managing client portfolios in a manner that prioritizes the adviser’s own tax efficiency over client interests.

Unauthorized Trading and Churning

Unauthorized trading — executing transactions without proper client authorization — violates FINRA Rule 2010, which codifies the requirement that members observe high standards of commercial honor and just and equitable principles of trade in the conduct of their business. Conduct inconsistent with a client’s instructions falls squarely within Rule 2010’s requirements and frequently grounds investor claims alongside common-law and statutory theories. Churning involves excessive trading to generate commissions and may be assessed under Reg BI, FINRA Rule 2111’s quantitative suitability component where applicable, and common-law theories depending on timing and account type. These violations can be difficult to detect because trade confirmations and account statements may not clearly convey the cumulative cost of excessive activity. High-net-worth investors are particularly exposed because larger accounts may absorb transaction costs that would immediately bankrupt smaller accounts, allowing misconduct to continue undetected for longer periods.

Reg BI, Fiduciary Duties, and State Remedies: Why the Distinctions Matter

Many high-net-worth investors work with both a broker-dealer account (for transaction-based products) and an RIA (for managed portfolios). These relationships carry distinct legal obligations and recovery theories, and the differences matter for both identifying the correct claim and choosing the right forum.

A common error in investment fraud cases is treating Reg BI and the Investment Advisers Act fiduciary standard as identical. They are not. An RIA managing a discretionary portfolio owes a full fiduciary duty encompassing loyalty and care that extends to every investment decision, not merely to specific recommended transactions. A broker-dealer’s Care Obligation under Reg BI applies at the point of recommendation; it does not impose continuous monitoring obligations in the same way an RIA’s ongoing fiduciary duty does.

Reg BI does not create a new private right of action or a standalone rescission remedy. In investor disputes, Reg BI violations may support the standard-of-conduct theory in FINRA arbitration or help frame related state-law, negligence, fiduciary-duty, or federal securities claims where those claims independently satisfy their elements. Investment Advisers Act § 206 likewise supports SEC enforcement and fiduciary-duty standards, but private damages claims against advisers usually require a separate cause of action or a limited rescission theory where applicable.

Federal Recovery Claims for Securities Fraud

§ 10(b) and Rule 10b-5

The primary federal anti-fraud provision for private securities litigation is § 10(b) of the Securities Exchange Act of 1934, 15 U.S.C. § 78j(b), implemented by SEC Rule 10b-5. To state a private cause of action under § 10(b) and Rule 10b-5, an investor must plead and prove: (1) a material misrepresentation or omission; (2) scienter (intent to deceive or recklessness); (3) a connection with the purchase or sale of securities; (4) reliance; (5) economic loss; and (6) loss causation.

The Private Securities Litigation Reform Act (PSLRA), 15 U.S.C. § 78u-4(b), requires claimants in federal court to identify each allegedly misleading statement with particularity, disclose the reasons each statement was misleading, and plead facts giving rise to a strong inference of scienter. FINRA arbitration under Rule 12200 is not subject to PSLRA’s heightened pleading standards — investors with parallel court and arbitration options face materially different evidentiary thresholds depending on forum selection, which affects how and where high-net-worth investors should pursue their claims. That procedural advantage must be weighed against FINRA’s more limited discovery tools and the narrow grounds for award review, especially where non-FINRA issuers, fund managers, or promoters are central parties.

§ 20(a) — Controlling Person Liability

§ 20(a) of the Securities Exchange Act, 15 U.S.C. § 78t(a), extends liability to persons who control others who violate the Exchange Act. In the context of high-net-worth investment fraud, § 20(a) can reach the brokerage firm (as a controlling person of the registered representative who committed the misconduct), the fund manager (as a controlling person of the fund), or corporate officers who directed fraudulent activities. In the Ninth Circuit, a § 20(a) prima facie claim requires showing a primary Exchange Act violation and that the defendant exercised direct or indirect control over the primary violator; the defendant may then assert the statutory good-faith and non-inducement defense. See Howard v. Everex Systems, Inc., 228 F.3d 1057, 1065 (9th Cir. 2000).

California State Law Claims

California investors have additional remedies under the California Corporate Securities Law of 1968. These state law claims operate alongside (not instead of) FINRA arbitration claims under FINRA Rule 12200 and federal § 10(b) claims for the same underlying conduct. Cal. Corp. Code § 25401 makes it unlawful for any person, in connection with the offer or sale of securities, to make any untrue statement of a material fact or omit to state a material fact necessary to make the statements not misleading. Cal. Corp. Code § 25501 provides a private remedy against the person who sells a security to, or purchases a security from, the investor in violation of § 25401. The seller or purchaser can avoid liability by showing the investor knew of the untruth or omission, or that the seller or purchaser exercised reasonable care and did not know of it. Claims against non-seller participants usually require a separate theory, such as Cal. Corp. Code § 25504 control-person liability, common-law fiduciary duty, or a federal securities claim.

For securities claims in California, the applicable statute of limitations under Corporations Code § 25506(b) runs to the earlier of: five years from the date of the violation, or two years from the date of discovery of the facts constituting the violation. California courts apply an inquiry-notice standard, meaning the period may begin when the investor knew or should have known through reasonable diligence. Note that the FINRA Rule 12206 six-year eligibility period and the California § 25506(b) limitations period run from different triggering events and may produce different deadlines for the same underlying misconduct.

Time Limits for High-Net-Worth Investment Fraud Claims

Investment fraud claims are time-sensitive. Different claims carry different deadlines, and failing to account for the correct period can bar recovery entirely.

A critical distinction: FINRA Rule 12206 runs from the occurrence or event giving rise to the claim, not from when the investor discovered the misconduct. When a claim involves multiple acts of misconduct over time, the six-year eligibility analysis may focus on the most recent occurrence rather than only the first transaction. State-law discovery rules do not automatically extend the Rule 12206 eligibility period. Investors with claims approaching the six-year mark must assess whether to file in FINRA arbitration, in court, or both — and that assessment requires counsel familiar with how arbitration panels apply Rule 12206 in the specific factual context.

Recovery Options: FINRA Arbitration vs. Court Litigation

For disputes involving registered broker-dealers and their associated persons, FINRA Rule 12200 provides that customers may compel FINRA arbitration of any dispute arising in connection with the member’s business activities — even where no separate arbitration agreement exists. The vast majority of high-net-worth investor disputes against brokerage firms proceed through FINRA arbitration because customer agreements typically contain mandatory arbitration clauses, and because FINRA’s forum offers several strategic advantages: lower evidentiary formalism than federal court, an industry-experienced panel familiar with securities market practices, and a relatively streamlined pretrial process.

For claims exceeding $100,000, FINRA Rule 12401 generally provides for a three-arbitrator panel, and Rule 12403’s list-selection process permits parties to strike non-public arbitrators, which can result in an all-public panel. FINRA arbitration also does not include depositions as standard discovery. That can matter in complex fraud disputes where testimony from promoters, supervisors, or third-party witnesses is central to the claim.

Disputes against unregistered promoters of fraudulent private placements, investment advisers not subject to FINRA jurisdiction, or entities that are not FINRA members typically proceed in court. California Superior Court and the U.S. District Court for the Central District of California (C.D. Cal.) are the primary securities litigation venues for California-based investors whose claims fall outside FINRA’s arbitration jurisdiction.

The Insider Advantage in High-Net-Worth Fraud Cases

A decade defending broker-dealers at Sichenzia Ross Ference LLP provides Gary Varnavides a specific vantage point now applied exclusively on behalf of investors. That defense-side background translates into concrete strategic advantages in high-net-worth fraud cases:

Gary Varnavides has been recognized as a New York Super Lawyers Rising Star in securities litigation for nine consecutive years (2015–2023). He is licensed in California and New York, with federal court admissions in the Central District of California, Southern District of New York, and Eastern District of New York. He is the author of “The Flawed State of Broker-Dealer Regulation,” recognized with the IMCA Richard J. Davis Legal/Regulatory/Ethics Award — a publication analyzing the structural gaps in broker-dealer oversight that are at the center of many investor claims.

Protecting Yourself Before Losses Occur

High-net-worth investors should preserve and review verification records for any disputed investment, particularly private offerings. FINRA BrokerCheck provides free public access to broker and firm records, including customer complaints, regulatory actions, and arbitration awards — checking those records takes minutes and can help document what was knowable before the investment.

If You Suspect Investment Fraud: Immediate Steps

Prompt action preserves evidence and protects legal rights. Securities law claims carry specific time limits; delay can narrow or eliminate recovery options.

Frequently Asked Questions

For high-net-worth investors, the central point is straightforward: accredited-investor status does not waive broker or adviser duties, and wealth alone does not make a fraudulent or unsuitable recommendation lawful. The right recovery path depends on the parties involved, the product sold, the documents signed, and the deadlines already running, so the claim should be assessed before evidence disappears or forum options narrow.

Schedule a Free Consultation